JG
INFI

Jefferies Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Jefferies Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-130,000
Closed -$173K – 2519
2016
Q2 		$173K Hold
130,000
– – ﹤0.01% 1852
2016
Q1 		$685K Buy
+130,000
New +$796K ﹤0.01% 1301
2014
Q1 		– Sell
-86,200
Closed -$1.19M – 2452
2013
Q4 		$1.19M Sell
86,200
-23,800
-22% -$336K 0.01% 757
2013
Q3 		$1.92M Sell
110,000
-175,100
-61% -$3.35M 0.02% 622
2013
Q2 		$4.62M Buy
+285,100
New +$8.82M 0.05% 272

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

Jefferies Group's INFI Position: Q2 2021 in Review

Jefferies Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2021, closing a stake of 13,500 shares — an estimated $43.6K sold.

Jefferies Group first reported a position in INFI in Q2 2013 and held it in 6 quarters. The position peaked at $950K in Q3 2013. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

  • Jefferies Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 13,500 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $43.6K.
  • Jefferies Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
  • Jefferies Group's Infinity Pharmaceuticals, Inc. position peaked at $950K in Q3 2013.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.